BY OBIEJESI PAMELA
The National Agency for Food and Drug Administration Control (NAFDAC) has refuted the claim by the Senate that banned anti-malarial drugs are in circulation in the country.
Briefing newsmen on Tuesday in Lagos, NAFDAC Acting DG, Dr Yetunde Oni, explained that, the said banned drugs are oral Mono-therapies which are no longer in use.
In her words “we want to douse the tension, and correct the misinformation on the social and mainstream media about the 42 anti-malarial medicines purportedly banned by the European Union but allegedly in circulation in the country.
“It is pertinent to mention that the allegedly banned ant-imalarial medicines are oral Monotherapies containing single active pharmaceutical ingredients (API) such as Artesunate as contained in Arinate tablet.
“Others are Amodiaquine as contained in Camoquine, Dihydroartemisinin contained in Daraprim tablet”.
Oni added that the recommended antimalarial medicines for the treatment of malaria in Nigeria are the Artemisin Combination Therapies (ACTs), which are in line with the guidelines for the treatment of malaria, 3rd edition, world Health Organization 2015 Geneva Switzerland.
She also advised Nigerians to pay attention to the scratch and text techniques on anti-malarial drugs before purchasing; as their first line of checking the quality of the medicine.
The post No Banned Anti-malarial Drugs In Nigeria Says NAFDAC appeared first on leadership.ng.